Achondroplasia: Recent advances in diagnosis and treatment
Achondroplasia: Recent advances in diagnosis and treatment
复制标题
软骨发育不全:诊断和治疗的最新进展
DOI:
--
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Hiroyuki Tanaka
中科院分区:
文献类型:
--
作者:
Hiroyuki Tanaka
Achondroplasia (ACH) is the most common form of chondrodysplasia in humans. This disorder is inherited as an autosomal dominant trait, though most cases are sporadic. Recent advances in molecular biology have revealed its genetic defect in fibroblast growth factor‐3 gene. This may introduce a new diagnostic tool and the classification of ACH and related disorders. Recent molecular engineering techniques have made it possible to provide large amounts of the various kinds of biofactors, such as erythropoietin, granulocyte colony stimulating factor and human growth hormone (GH), for clinical use. In fact, GH has been widely used to treat non‐GH‐deficient forms of short stature, such as Turner's syndrome, skeletal dysplasia, intrauterine growth retardation, chronic illness and idiopathic short stature, with beneficial effects. This may also be introduced into the medical management of ACH.
登录
查看更多内容
影响因子:
4.4
作者:
Thompson,LM;Plummer,S;Schalling,M;Altherr,MR;Gusella,JF;Housman,DE;Wasmuth,JJ
通讯作者:
Wasmuth,JJ
影响因子:
3.5
作者:
Francomano,CA;OrtizdeLuna,RI;Hefferon,TW;Bellus,GA;Turner,CE;Taylor,E;Meyers,DA;Blanton,SH;Murray,JC;McIntosh,I
通讯作者:
McIntosh,I
DOI:
10.1073/pnas.82.16.5465
发表时间:
1985
影响因子:
11.1
作者:
Eng,CE;Pauli,RM;Strom,CM
通讯作者:
Strom,CM
影响因子:
9.8
作者:
Hecht,JT;Francomano,CA;Horton,WA;Annegers,JF
通讯作者:
Annegers,JF
DOI:
10.1073/pnas.88.4.1095
发表时间:
1991-02-01
影响因子:
11.1
作者:
KEEGAN, K;JOHNSON, DE;HAYMAN, MJ
通讯作者:
HAYMAN, MJ